Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 55.8B | 59.1B | 56.6B | 60.7B |
| Cost of revenue | 47.5B | 48.3B | 50.8B | 51.2B |
| Gross profit | 8.3B | 10.8B | 5.8B | 9.5B |
| Operating expense | ||||
| Research & development | 237.4M | 158.0M | 282.6M | 251.0M |
| Selling general and admin | 2.6B | 2.4B | 2.8B | 2.7B |
| Other operating expenses | 307.4M | 179.3M | 734.3M | 260.4M |
| Operating income | 5.1B | 8.1B | 2.1B | 6.3B |
| Non operating interest income | ||||
| Income | 513.1M | 483.3M | 158.0M | 664.3M |
| Expense | 917.8M | 956.3M | 1.1B | 1.0B |
| Other income expense | — | — | — | — |
| Pretax income | 5.1B | 7.6B | 3.6B | 6.2B |
| Tax provision | 2.0B | 3.5B | 2.7B | 2.5B |
| Net income | 3.1B | 4.2B | 888.8M | 3.7B |
| Basic EPS | — | 1.6 | 0.3 | 1.4 |
| Diluted EPS | — | 1.6 | 0.3 | 1.4 |
| Basic average shares | — | 2.6B | 2.6B | 2.7B |
| Diluted average shares | — | 2.6B | 2.7B | 2.7B |
| EBITDA | 10.6B | 13.4B | 7.7B | 12.4B |
| Net income from continuing op. | 5.1B | 7.6B | 3.6B | 6.2B |
| Minority interests | -36.7M | -81.1M | -96.5M | -85.4M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |